PIMJS
REGN icon

PKO Investment Management Joint-Stock’s Regeneron Pharmaceuticals REGN Stock Holding History

PKO Investment Management Joint-Stock’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.68M Buy
5,900
+150
+3% +$102K 0.27% 74
2026
Q1 		$4.44M Buy
5,750
+900
+19% +$689K 0.37% 61
2025
Q4 		$3.74M Sell
4,850
-6,350
-57% -$4.31M 0.3% 75
2025
Q3 		$6.3M Sell
11,200
-7,600
-40% -$4.3M 0.54% 42
2025
Q2 		$9.87M Buy
18,800
+3,500
+23% +$1.95M 1.06% 23
2025
Q1 		$9.7M Buy
15,300
+4,500
+42% +$3.1M 1.1% 21
2024
Q4 		$7.69M Buy
10,800
+10,000
+1,250% +$8.39M 0.96% 18
2024
Q3 		$841K Buy
800
+500
+167% +$556K 0.1% 120
2024
Q2 		$315K Hold
300
– – 0.04% 159
2024
Q1 		$290K Hold
300
– – 0.03% 152
2023
Q4 		$263K Hold
300
– – 0.03% 139
2023
Q3 		$247K Sell
300
-800
-73% -$629K 0.03% 130
2023
Q2 		$790K Buy
1,100
+900
+450% +$694K 0.1% 115
2023
Q1 		$164K Sell
200
-400
-67% -$302K 0.02% 141
2022
Q4 		$433K Hold
600
– – 0.06% 122
2022
Q3 		$413K Sell
600
-600
-50% -$378K 0.07% 115
2022
Q2 		$709K Hold
1,200
– – 0.1% 102
2022
Q1 		$838K Sell
1,200
-1,092
-48% -$691K 0.1% 100
2021
Q4 		$1.45M Buy
2,292
+1,592
+227% +$979K 0.16% 88
2021
Q3 		$424K Hold
700
– – 0.05% 102
2021
Q2 		$391K Hold
700
– – 0.05% 92
2021
Q1 		$331K Hold
700
– – 0.05% 79
2020
Q4 		$338K Hold
700
– – 0.06% 72
2020
Q3 		$392K Hold
700
– – 0.08% 70
2020
Q2 		$437K Hold
700
– – 0.1% 68
2020
Q1 		$342K Buy
+700
New +$289K 0.12% 66

Other funds holding REGN

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
MCI
McDonald Capital Investors Orinda, California $1.37B AUM 1.88% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Retirement Systems of Alabama
Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

PKO Investment Management Joint-Stock's REGN Position: Q2 2026 in Review

PKO Investment Management Joint-Stock increased its Regeneron Pharmaceuticals (REGN) stake by 2.6% in Q2 2026, buying an estimated $102K and bringing the position to 5,900 shares worth $3.68M. The position accounts for 0.27% of the portfolio, ranked #74.

PKO Investment Management Joint-Stock first reported a position in REGN in Q1 2020 and has held it in 26 quarters since. The position peaked at $9.87M in Q2 2025. 518 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • PKO Investment Management Joint-Stock held 5,900 shares of Regeneron Pharmaceuticals worth $3.68M as of Q2 2026.
  • PKO Investment Management Joint-Stock bought 150 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $102K.
  • Regeneron Pharmaceuticals made up 0.27% of PKO Investment Management Joint-Stock's portfolio in Q2 2026, its #74 holding.
  • PKO Investment Management Joint-Stock first reported a position in Regeneron Pharmaceuticals in Q1 2020 and has held it in 26 quarters since.
  • PKO Investment Management Joint-Stock's Regeneron Pharmaceuticals position peaked at $9.87M in Q2 2025.
  • 518 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on PKO Investment Management Joint-Stock's 13F filing for Q2 2026, filed 20 Jul 2026.